- Home
- MNPR vs ELMD Comparison
MNPR vs ELMD Comparison
Compare MNPR & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- ELMD
- Stock Information
- Founded
- MNPR 2014
- ELMD 1992
- Country
- MNPR United States
- ELMD United States
- Employees
- MNPR N/A
- ELMD N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MNPR Health Care
- ELMD Health Care
- Exchange
- MNPR Nasdaq
- ELMD Nasdaq
- Market Cap
- MNPR 248.8M
- ELMD 206.5M
- IPO Year
- MNPR 2019
- ELMD 2010
- Fundamental
- Price
- MNPR $44.21
- ELMD $24.47
- Analyst Decision
- MNPR Strong Buy
- ELMD Strong Buy
- Analyst Count
- MNPR 10
- ELMD 2
- Target Price
- MNPR $66.56
- ELMD $35.50
- AVG Volume (30 Days)
- MNPR 38.8K
- ELMD 77.6K
- Earning Date
- MNPR 11-07-2025
- ELMD 08-26-2025
- Dividend Yield
- MNPR N/A
- ELMD N/A
- EPS Growth
- MNPR N/A
- ELMD 46.55
- EPS
- MNPR N/A
- ELMD 0.85
- Revenue
- MNPR N/A
- ELMD $64,000,000.00
- Revenue This Year
- MNPR N/A
- ELMD $11.25
- Revenue Next Year
- MNPR N/A
- ELMD $8.82
- P/E Ratio
- MNPR N/A
- ELMD $28.79
- Revenue Growth
- MNPR N/A
- ELMD 16.97
- 52 Week Low
- MNPR $2.29
- ELMD $16.40
- 52 Week High
- MNPR $54.30
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- MNPR 65.29
- ELMD 68.92
- Support Level
- MNPR $32.77
- ELMD $23.61
- Resistance Level
- MNPR $36.49
- ELMD $25.33
- Average True Range (ATR)
- MNPR 2.93
- ELMD 1.03
- MACD
- MNPR 1.14
- ELMD 0.45
- Stochastic Oscillator
- MNPR 99.97
- ELMD 86.71
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.